Buprenorphine vs methadone treatment: A review of evidence in both developed and developing worlds.
about
Opioid Substitution Treatment Planning in a Disaster Context: Perspectives from Emergency Management and Health Professionals in Aotearoa/New ZealandA review of a national training initiative to increase provider use of MAT to address the opioid epidemic.Evaluation of 6 remote First Nations community-based buprenorphine programs in northwestern Ontario: Retrospective study.The effectiveness of opioid substitution treatments for patients with opioid dependence: a systematic review and multiple treatment comparison protocol.Commentary.Opioid dependency rehabilitation with the opioid maintenance treatment programme - a qualitative study from the clients' perspectiveExaggerated acquisition and resistance to extinction of avoidance behavior in treated heroin-dependent menPatients' Beliefs About Medications are Associated with Stated Preference for Methadone, Buprenorphine, Naltrexone, or no Medication-Assisted Therapy Following Inpatient Opioid Detoxification.Retention in medication-assisted treatment for opiate dependence: A systematic review.New Pain Management Options for the Surgical Patient on Methadone and Buprenorphine.Drug-induced torsades de pointes in an underserved urban population. Methadone: is there therapeutic equipoise?Buprenorphine-induced psychotic symptoms: a case report.Prescription Opioid Misuse and Public Health Approach in Australia.Buprenorphine, Norbuprenorphine, R-Methadone, and S-Methadone Upregulate BCRP/ABCG2 Expression by Activating Aryl Hydrocarbon Receptor in Human Placental Trophoblasts.Delay-Dependent Impairments in Memory and Motor Functions After Acute Methadone Overdose in RatsSexual life satisfaction of methadone-maintained Chinese patients: individuals with pain are dissatisfied with their sex lives
P2860
Q30151620-CDF8C1DD-5F6F-45D8-A3F0-ACE00385E473Q30239840-933A59EC-E6CD-4FFF-AA3A-47F5E2B56963Q33574968-88DB47F4-4CB2-4F80-BAD2-E6F76CB05374Q34226309-D1D16E7A-69B8-4043-9449-E213A20F743BQ35733017-B535A609-47D1-423A-8EB7-66EC61FDC82BQ36063225-44F883B9-1F23-4750-98AE-818AA40584BBQ36771103-C1F4CBEE-BDE6-431D-8D56-AC446D23808AQ36967059-CDED985B-CF5F-4926-BC0F-3C00DA1E9C4CQ38607448-B72440F2-B0AC-4626-B811-AFF61F7D2E3BQ38734748-80AF581A-8A5E-4569-833C-4885F1B42468Q40294759-0F04E06B-097B-495C-8A06-9DC03925CB51Q42781831-0EB7CBF6-EAF8-4948-B739-B5EDE9982AE2Q44346434-688C2882-5503-40C5-AC09-59AA1069BAD4Q48901790-73B9DCB9-C824-4D44-B8D3-13212633FB5CQ58754221-BB61BAB2-582D-42B1-B2E8-9D781A0CE854Q58754575-1BB0CF8E-2D28-40F2-AE64-77DCC335AD42
P2860
Buprenorphine vs methadone treatment: A review of evidence in both developed and developing worlds.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Buprenorphine vs methadone tre ...... veloped and developing worlds.
@ast
Buprenorphine vs methadone tre ...... veloped and developing worlds.
@en
type
label
Buprenorphine vs methadone tre ...... veloped and developing worlds.
@ast
Buprenorphine vs methadone tre ...... veloped and developing worlds.
@en
prefLabel
Buprenorphine vs methadone tre ...... veloped and developing worlds.
@ast
Buprenorphine vs methadone tre ...... veloped and developing worlds.
@en
P2860
P356
P1476
Buprenorphine vs methadone tre ...... veloped and developing worlds.
@en
P2093
Kimberly Remski
Paul J Whelan
P2860
P356
10.4103/0976-3147.91934
P577
2012-01-01T00:00:00Z